You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 4, January 28, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (33)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Headache
 •Migraine
 •Alert me on articles by topic

Is Migraine a Progressive Brain Disease?

Richard B. Lipton, MD; Jullie Pan, MD, PhD

JAMA. 2004;291:493-494.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of THE JOURNAL, Kruit and colleagues1 provide important new data on the prevalence of brain infarction and white matter lesions in persons with migraine. The authors systematically recruited individuals with migraine with aura and migraine without aura as well as group-matched controls without migraine from the general Dutch population. By using population surveys, the authors identified a representative sample of migraine cases, addressing concerns about selection bias in earlier studies.2-4 An appropriate population control group without migraine was recruited from the screened sample. The use of 3-mm magnetic resonance imaging (MRI) sections improved lesion detection, and imaging studies were interpreted masked to case status, minimizing bias in the assessment of radiographic findings. Demographic factors, cardiovascular diseases, headache features, and treatment patterns were carefully assessed so that these potential confounders and effect modifiers could be taken into account.

Using these . . . [Full Text of this Article]

Author Affiliation: Departments of Neurology, Epidemiology and Public Health (Dr Lipton) and Neuroscience (Dr Pan), Albert Einstein College of Medicine, Bronx, NY.


RELATED ARTICLE

Migraine as a Risk Factor for Subclinical Brain Lesions
Mark C. Kruit, Mark A. van Buchem, Paul A. M. Hofman, Jacobus T. N. Bakkers, Gisela M. Terwindt, Michel D. Ferrari, and Lenore J. Launer
JAMA. 2004;291(4):427-434.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevalence and characteristics of allodynia in headache sufferers: A population study
Bigal et al.
Neurology 2008;70:1525-1533.
ABSTRACT | FULL TEXT  

A Practical Approach to Headache Treatment
Tucker
Journal of Pharmacy Practice 2007;20:123-136.
ABSTRACT  

Migraine prevalence, disease burden, and the need for preventive therapy
Lipton et al.
Neurology 2007;68:343-349.
ABSTRACT | FULL TEXT  

Advances in Migraine Treatment
Nissan and Diamond
JAOA: Journal of the American Osteopathic Association 2005;105:9S-15S.
ABSTRACT | FULL TEXT  

Long-term effects of migraine on cognitive function: A population-based study of Danish twins
Gaist et al.
Neurology 2005;64:600-607.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.